Patents Assigned to VIRACOR-IBT LABORATORIES
  • Publication number: 20140227303
    Abstract: Methods and assays for disease prognosis, detection and treatment monitoring are provided. The assays and methods measure functional immune responses to disease modified biomolecules (DMBs) that are characteristic of a disease of interest. Exemplary diseases of interest include rheumatoid arthritis (RA), for which citruUinated peptides or proteins (CPs), are characteristic DMBs.
    Type: Application
    Filed: June 29, 2012
    Publication date: August 14, 2014
    Applicant: VIRACOR-IBT LABORATORIES
    Inventors: Jianrong Lou, Brad L. Stewart, Nathaniel Rill
  • Patent number: 8236514
    Abstract: In certain embodiments, the present invention relates to methods, compositions, and kits for diagnosing autoimmune chronic urticaria. For example, in certain embodiments, such methods generally comprise detecting the presence of auto-antibodies to cell-surface IgE receptors or cell-bound IgE in a patient.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: August 7, 2012
    Assignee: Viracor-IBT Laboratories, Inc.
    Inventors: John Frederick Halsey, Michelle Lee Altrich
  • Patent number: 7824877
    Abstract: In certain embodiments, the present invention relates to methods, compositions, and kits for diagnosing autoimmune chronic urticaria. For example, in certain embodiments, such methods generally comprise detecting the presence of auto-antibodies to cell-surface IgE receptors or cell-bound IgE in a patient.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: November 2, 2010
    Assignee: Viracor-IBT Laboratories, Inc.
    Inventors: John Frederick Halsey, Michelle Lee Altrich